Moreover, we searched for CD34+/NPM1 cytoplasmic precursors in the bone marrow (BM) biopsies of NPM1-AML patients at diagnosis and relapse, using a highly specific monoclonal antibody against mutant NPM1. Here, NPM1 is linked to acute myeloid leukemia.